[Skip to Content]
[Skip to Content Landing]
Citations 0
Medical News and Perspectives
March 9, 2005

Preventive Antiretroviral Use Expands

JAMA. 2005;293(10):1177-1178. doi:10.1001/jama.293.10.1177

After years of uncertainty, the US government has determined that sufficient evidence exists to sanction the use of antiretroviral drugs to prevent HIV infection following nonoccupational exposure to the virus. Experts caution, however, that prophylactic antiretroviral drugs should be used sparingly, only when the risk of transmission is substantial.

“These guidelines are intended for use in limited circumstances for individuals who are not at high ongoing risk of infection,” said Ronald O. Valdiserri, MD, MPH, deputy director of the National Center for HIV, STD and TB Prevention of the Centers for Disease Control and Prevention (CDC).

First Page Preview View Large
First page PDF preview
First page PDF preview